Total Funding
48
44
Total FundingPost-IPO Equity raised
Growth Score
-4 pts
Heat Score
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
167281
Nuo Therapeutics develops biological therapies to address the areas of wound care, inflammation, and angiogenesis.
Pete Clausen: CSO/COO
David Jorden: Bord of DirectorsPast Role: Fayez Sarofim & Co., Principal
About the Company
Nuo Therapeutics is a biotechnology company that develops, sells, and licenses regenerative biological therapies to primarily address the areas of wound care, inflammation, and angiogenesis. The Company markets the AutoloGel System, a device for the production of platelet rich plasma gel derived from the patient's own blood. The AutoloGel
System is cleared by the United States Food and Drug Administration for use on a variety of exuding wounds.
Nuo Therapeutics is headquartered in Gaithersburg, Maryland.
